Olga Bogatyrova

2.2k total citations
16 papers, 785 citations indexed

About

Olga Bogatyrova is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Olga Bogatyrova has authored 16 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Olga Bogatyrova's work include Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer-related gene regulation (3 papers). Olga Bogatyrova is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Cancer Genomics and Diagnostics (4 papers) and Cancer-related gene regulation (3 papers). Olga Bogatyrova collaborates with scholars based in Germany, United States and Spain. Olga Bogatyrova's co-authors include Christoph Plass, Rainer Claus, Peter Lichter, Anders M. Lindroth, Stefan M. Pfister, Manuela Zucknick, Yassen Assenov, Christopher C. Oakes, David Brocks and Jan O. Korbel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Reviews Genetics.

In The Last Decade

Olga Bogatyrova

15 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Bogatyrova Germany 8 587 279 147 130 87 16 785
Dale Butterfoss United States 3 550 0.9× 181 0.6× 97 0.7× 273 2.1× 29 0.3× 5 786
Meng-Hong Sun China 14 517 0.9× 247 0.9× 107 0.7× 248 1.9× 31 0.4× 20 785
Hendrik F. van Essen Netherlands 13 326 0.6× 276 1.0× 107 0.7× 278 2.1× 56 0.6× 22 775
Koichi Fukino Japan 14 451 0.8× 252 0.9× 151 1.0× 462 3.6× 56 0.6× 19 824
Anna Dowe United Kingdom 13 537 0.9× 264 0.9× 335 2.3× 245 1.9× 99 1.1× 15 951
Daniel C. Koboldt United States 9 313 0.5× 247 0.9× 202 1.4× 461 3.5× 96 1.1× 19 804
Caterina Vicentini Italy 17 558 1.0× 518 1.9× 115 0.8× 310 2.4× 47 0.5× 32 955
Melinda S. Gordon United States 10 394 0.7× 251 0.9× 76 0.5× 195 1.5× 66 0.8× 25 683
Tanaya Neff United States 14 271 0.5× 263 0.9× 275 1.9× 190 1.5× 50 0.6× 23 642
Robyn Lukeis Australia 13 273 0.5× 149 0.5× 91 0.6× 202 1.6× 61 0.7× 25 580

Countries citing papers authored by Olga Bogatyrova

Since Specialization
Citations

This map shows the geographic impact of Olga Bogatyrova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Bogatyrova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Bogatyrova more than expected).

Fields of papers citing papers by Olga Bogatyrova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Bogatyrova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Bogatyrova. The network helps show where Olga Bogatyrova may publish in the future.

Co-authorship network of co-authors of Olga Bogatyrova

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Bogatyrova. A scholar is included among the top collaborators of Olga Bogatyrova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Bogatyrova. Olga Bogatyrova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Budzinska, Magdalena A., Olga Bogatyrova, F. Neumann, et al.. (2023). DNA-Dependent Protein Kinase Inhibitor Peposertib Potentiates the Cytotoxicity of Topoisomerase II Inhibitors in Synovial Sarcoma Models. Cancers. 16(1). 189–189. 2 indexed citations
3.
Friese‐Hamim, Manja, Olga Bogatyrova, Felix Rohdich, et al.. (2023). Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models. Molecular Cancer Therapeutics. 23(2). 159–173. 1 indexed citations
4.
Barrdahl, Myrto, Yassen Assenov, Anika Hüsing, et al.. (2022). Identification of NHLRC1 as a Novel AKT Activator from a Lung Cancer Epigenome-Wide Association Study (EWAS). International Journal of Molecular Sciences. 23(18). 10699–10699. 3 indexed citations
5.
Bogatyrova, Olga, Johanna Sofia Margareta Mattsson, Edith Ross, et al.. (2021). FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response. European Journal of Cancer. 151. 136–149. 32 indexed citations
6.
Friese‐Hamim, Manja, Dominique Perrin, Olga Bogatyrova, et al.. (2021). Brain penetration and efficacy of tepotinib in orthotopic patient-derived xenograft models of MET-driven non-small cell lung cancer brain metastases. Lung Cancer. 163. 77–86. 14 indexed citations
7.
Laplana, Marina, Matthias Bieg, Svitlana Melnik, et al.. (2021). Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers. Epigenetics. 17(2). 117–132. 2 indexed citations
8.
Friese‐Hamim, Manja, Olga Bogatyrova, Claudia Wilm, et al.. (2020). Abstract 3407: Anti-tumor activity of tepotinib in orthotopic models of lung cancer patient-derived brain metastases with MET amplification. Cancer Research. 80(16_Supplement). 3407–3407.
9.
Friese‐Hamim, Manja, Olga Bogatyrova, María J. Ortiz, et al.. (2019). Abstract 3075: Antitumor activity of M8891, a potent and reversible inhibitor of methionine aminopeptidase 2. Cancer Research. 79(13_Supplement). 3075–3075. 1 indexed citations
10.
Brocks, David, Yassen Assenov, Sarah Minner, et al.. (2014). Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer. Cell Reports. 8(3). 798–806. 192 indexed citations
11.
Oakes, Christopher C., Rainer Claus, Lei Gu, et al.. (2013). Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia. Cancer Discovery. 4(3). 348–361. 110 indexed citations
12.
Plass, Christoph, Stefan M. Pfister, Anders M. Lindroth, et al.. (2013). Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nature Reviews Genetics. 14(11). 765–780. 323 indexed citations
13.
Goeppert, Benjamin, Carolin Konermann, Christopher R. Schmidt, et al.. (2013). Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway. Hepatology. 59(2). 544–554. 88 indexed citations
14.
Bogatyrova, Olga, et al.. (2013). Genetic and epigenetic changes of GPX1 and GPX3 in human clear-cell renal cell carcinoma. Biopolymers and Cell. 29(5). 395–401. 7 indexed citations
15.
Oakes, Christopher C., Rainer Claus, Lei Gu, et al.. (2013). Heterogeneity and Evolution Of DNA Methylation In Chronic Lymphocytic Leukemia. Blood. 122(21). 1626–1626. 1 indexed citations
16.
Брага, Э. А., В. И. Логинов, Д. С. Ходырев, et al.. (2011). A novel MECA3 region in human 3p21.3 harboring putative tumor suppressor genes and oncogenes.. PubMed. 33(1). 33–41. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dale Butterfoss Breakdown of academic impact, for papers by Meng-Hong Sun Breakdown of academic impact, for papers by Hendrik F. van Essen Breakdown of academic impact, for papers by Koichi Fukino Breakdown of academic impact, for papers by Anna Dowe Breakdown of academic impact, for papers by Daniel C. Koboldt Breakdown of academic impact, for papers by Caterina Vicentini Breakdown of academic impact, for papers by Melinda S. Gordon Breakdown of academic impact, for papers by Tanaya Neff Breakdown of academic impact, for papers by Robyn Lukeis
Rankless by CCL
2026